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In the third season (2002) of the West Nile virus epi-
demic in the United States, two canids (wolf and dog) were
diagnosed with West Nile virus encephalitis and myocardi-
tis with similarities to known affected species (humans,
horses, and birds). The West Nile virus infections were con-
firmed by immunohistochemistry and polymerase chain
reaction.
S
ince its 1999 introduction in New York, West Nile
virus (WNV) has spread to >40 states, causing season-
al mosquito-borne disease in humans, horses, and birds
(1–7). We recently identified two Illinois canids (a captive
wolf and a domestic dog) with severe disease associated
with WNV infection. 
Outside the Western Hemisphere, WNV has been
endemic for decades (4,8–11). Canids have not been
thought to be important in the epidemiology of this virus.
However, a dog with neurologic disease that died in Africa
in 1977 is now thought to have been infected with WNV
(9,12). In a recent study in which four dogs were experi-
mentally infected, no clinical disease was observed, and a
low viremia developed in one dog (11). Natural infections
occur in dogs, as indicated by serum antibodies; seroposi-
tivity in surveys was 37% in the 1980s in South Africa,
24% in the 1990s in India, and 5% in 1999 in New York
City (10,11,13). In addition, a few individuals of some
mammalian species have been listed as infected (not dis-
eased): 14 bats, four rodents, three rabbits, two cats, two
raccoons, and a skunk (6).
The Study
Two Illinois canids were brought in for necropsy in
August 2002: 1) a 3-month-old female wolf pup, which
died after 2 days of lethargy, depression, and irritability
that progressed to anorexia, weakness, ataxia, and blind-
ness and 2) an overweight 8-year-old castrated male Irish
Setter-Golden Retriever mixed breed dog that was eutha-
nized in moribund condition after a 7-day illness. The dog
was hospitalized after 3 days of lethargy, anorexia, poly-
dipsia, ocular discharge, and difficulty in rising that had
progressed to fever, listlessness, weakness, ptyalism, nasal
and ocular discharge, watery diarrhea, and abdominal pain.
Although the diarrhea resolved and the dog was stronger
and more alert the morning after hospitalization, over the
next 3 days, multisystemic clinical signs developed,
including dyspnea, diarrhea with melena, ataxia, a head tilt
with head bobbing, pulmonary edema, and cardiac
arrhythmias. While hospitalized, the dog had mild anemia
without spherocytes, moderate to severe thrombocytopenia
with large platelets, moderate leukocytosis with a left shift,
a moderate hypokalemia, a mild hypoglycemia, and
hypoproteinemia. Symptomatic and supportive care treat-
ment included broad-spectrum antibiotics, a gastrointesti-
nal protectant, a diuretic, fluid therapy, and systemic corti-
costeroids (for immune-mediated thrombocytopenia and
anemia).
Both the wolf and dog were necropsied. Samples of
multiple tissues were fixed and processed for routine diag-
nostic histopathology. In addition, tissues were screened
with peroxidase immunohistochemistry for distemper,
rabies, WNV, Toxoplasma, and  Neospora. Sections for
WNV immunohistochemistry were pretreated with 0.1%
protease (20 min at 37°C) and nonspecific antibody bind-
ing blocked with Power Block (BioGenx, San Ramon,
CA). The primary antibody was mouse anti-WNV mono-
clonal ascitic fluid diluted 1:1,000 (ATTC, Manassas, VA).
The wolf brain was assayed for rabies antigen by fluores-
cent antibody (Public Health Laboratory, Springfield, IL).
West Nile viral RNA in the brain of the wolf and the
kidney and liver of the dog (available cyropreserved tis-
sue) was assayed by using a modified 5′ nuclease fluoro-
genic real-time, reverse transcriptase polymerase chain
reaction assay (RT-PCR) (TaqMan, Applied Biosystems,
Foster City, CA) (14). Each amplification reaction con-
tained primers and probes (Table) (14,15) for both WNV
and St. Louis encephalitis virus (SLEV) with FAM (6-car-
boxyfluorescein) and VIC (Applied Biosystems) fluores-
cent-labeled probes, respectively. A tissue sample (about
200 µg) was homogenized in 1.5 mL of medium 199 with
L-glutamine, Hanks balanced salt solution, and 25 mM
HEPES in a microfuge tube with three 3.2-mm stainless
steel beads (Biospec Products, Bartlesville, OK). The sam-
ple was ground in a mixer mill for four min at a rate of 1/30
sec-1, and then centrifuged (4,000 X g, 4 min). RNA was
purified from 220 µL of the supernatant by using a viral
RNA purification kit and the Biorobot 9604 (QIAGEN,
Inc., Alameda, CA), eluting in a final volume of 85 µL.
Real-time, RT-PCR was done in a 25-µL reaction with
One-step RT-PCR Master Mix kit (Applied Biosystems)
containing 25 pmol of each primer set, 3.25 pmol of each
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reaction was run in an Applied Biosystems Sequencing
Detection System 7000 programmed for 48.0°C for 30
min, 95°C for 10 min, and 40 cycles of 95°C for 15 sec and
60°C for 1 min. RNA samples from WNV isolate NY99
(5) and SLEV were run in parallel for positive controls for
the amplification. 
At necropsy, the wolf had no gross lesions.
Histologically, the brain had encephalitis compatible with
a viral infection, including scattered blood vessels with
narrow rims of lymphocytes. Scattered in the gray matter
of all brain sections were random, poorly demarcated
aggregates of microglial cells and lymphocytes with rare
neutrophils and mild necrosis including an occasional
necrotic neuron (Figure 1A). The white matter contained
rare glial nodules. Each of two sections of heart had a
small focus of myocardial cell fragmentation with a few
lymphocytes and macrophages and fewer neutrophils. A
similar smaller focus was in one of the two sections of
skeletal muscle. The outer cortex of the adrenal gland had
several foci of two to five necrotic cells with a few lym-
phocytes. No major histologic changes were evident in the
kidney, lung, liver, spleen, tonsil, pancreas, small intestine,
colon, sciatic nerve, or bone marrow. 
The dog had several abnormalities at necropsy. The
major gross lesion was fibrinous epicarditis of the atria.
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Table. Sequence (5´ to 3´) of primers and probes used in real-time reverse transcriptase–polymerase chain reaction to assay for West 
Nile virus genome in canid tissue 
Item  West Nile virus  St. Louis encephalitis virus 
Forward primer  CAGACCACGCTACGGCG  GAAAACTGGGTTCTGCGCA 
Reverse primer  CTAGGGCCGCGTGGG  GTTGCTGCCTAGCATCCATCC 
Probe  TCTGCGGAGAGTGCAGTCTGCGAT  TGGATATGCCCTAGTTGCGCTGGC 
Figure 1. Encephalitis and myocarditis in two West Nile virus–infected canids. A, histopathology of the cerebrum of the wolf. Focus of
lymphocyte infiltration and necrosis with mild gliosis; arrow indicates necrotic neuron. Hematoxylin-eosin staining. B, histopathology of
the heart of the dog. Focus of leukocytic infiltration, mostly lymphocytes, and myocardial cell degeneration and necrosis. Hematoxylin-
eosin staining. C, West Nile virus immunohistochemistry of the cerebrum of the wolf. Intense labeling of neurons in focus of inflamma-
tion. Some labeling is also in the glial cells or lymphocytes. Immunoperoxidase with hematoxylin counterstain. D, West Nile virus immuno-
histochemistry of the heart of dog. Intense labeling of most myocardial cells in the field. Immunoperoxidase with hematoxylin counter-
stain.Other important findings included a hepatopathy (mottled
tan yellow with an uneven surface), pulmonary edema, and
two acute splenic infarcts. Histologically, the dog had a
polioencephalitis similar to the wolf’s, but much milder. In
addition, the basal ganglia area had a focus of malacia pre-
dominately cleared via foamy macrophages. The dog had
marked myocarditis (especially the atria) with numerous
loose aggregates of leukocytes associated with degenerat-
ed or necrotic myocardial cells (Figure 1B). Lymphocytes
predominated in the infiltrate; an occasional macrophage
and neutrophil contributed. Both the lung and liver had
changes compatible with heart failure: pulmonary edema,
marked hepatic congestion, and marked hepatocellular
fatty change with cholestasis. In addition to the acute
infarcts, the spleen had marked lymphoid atrophy and
marked hematopoiesis with hemosiderosis. The bone mar-
row was hyperplastic with proliferation of all three
hematopoietic lineages. The hemogram, melena, and
necropsy hematopoietic findings are most likely due to
immune-mediated thrombocytopenia and anemia, a spo-
radic idiopathic condition in dogs. 
No antigen was detected in either canid for canine dis-
temper, rabies, toxoplasmosis, or neosporosis, diseases
that can cause encephalitis or myocarditis. In contrast,
WNV immunolabeling was intense in the brain of the wolf
(Figure 1C). Abundant, intense labeling was associated
with the areas of inflammation; focally, the labeling was
grossly visible. Many neurons had intense labeling, and
less dense labeling was associated with glial cells or lym-
phocytes. In the gray matter between inflammatory nod-
ules, scattered individual neurons labeled intensely. Also
immunolabeled in the wolf were a few myocardial cells
and several small clusters of cells in the zona glomerulosa
of the adrenal gland. No labeling was identified in the kid-
ney and spleen. In the dog, the heart had intense immuno-
labeling in many myocardial cells (Figure 1D); the most
extensive labeling was in the atria. The labeling in the dog
brain was weak and inconclusive, and no label was found
in the spleen. The dog had viral immunolabeling in scat-
tered small foci of cells in the adrenal zona glomerulosa
and renal tubular epithelial cells.
In the PCR assay, the WNV amplicon was abundant in
the samples from the wolf brain (Figure 2), the dog kidney
(not shown), and NY99 isolate (Figure 2). Samples from
the dog liver failed to generate an amplicon signal. The
SLEV primers, as expected, generated amplicons for
SLEV control genome; the primers did not generate ampli-
cons from samples of canid tissue (Figure 2).
Discussion
The dog and wolf reported here are the first canids
reported with WNV disease in the U.S. outbreak. The
encephalitis in the canids affected the gray matter similar
to WNV disease in horses, whereas humans have inflam-
matory nodules in both the gray and white matter
(2,16,17). The myocarditis in the dog more closely resem-
bled the lesions of WNV-infected birds than the lesions
reported in mammals (2,3,17). Although crows and blue
jays usually die without evidence of inflammation, WNV
antigen is frequently demonstrated by immunohistochem-
istry in the hearts and in infected raptors, myocarditis is a
common finding (J. J. Andrews, pers. comm.). The dog
apparently had a concurrent, immune-mediated disease,
which may have increased susceptibility for WNV disease. 
Both of the canids likely were infected by bites from
infected mosquitoes. WNV has been detected in 12 species
of mosquitoes in Illinois, and four of these species prefer
mammalian hosts (R. Novak, unpub. data). Novel routes of
infection are also possible, such as ingestion of infected
birds. The epidemiology of WNV in canids is likely simi-
lar to that in humans: sporadic disease cases with no
important role in viral transmission or maintenance. More
investigation is needed to confirm the epidemiology of
WNV in canids and to monitor disease in other known and
novel host species.
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Figure 2. Real-time reverse transcriptase polymerase chain reac-
tion of RNA extracted from the wolf brain. The amplification was
duplexed with primers and probes for West Nile and St. Louis
encephalitis viruses detected with fluorochrome dyes, FAM and
VIC, respectively. Test and control samples were run in parallel
and in duplicate (extraction and amplification) with consistent
results. Delta reaction on the y axis represents the change in
threshold fluorescence. The box lists the source of the template
nucleic acid and the specificity of the fluorochrome probe (tem-
plate source-probe specificity). WNV, West Nile virus; NY99, an
isolate from the 1999 WNV outbreak in New York; SLEV, St. Louis
encephalitis virus; NTC, no template control. Acknowledgments
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